typical dose of semaglutide for weight loss Dosing Semaglutide Dosing for Weight Loss:

At 48 weeks, 93% of participants on the 12 mg dose achieved normal liver fat levels (below 5%), with a mean relative reduction of 86% in hepatic fat content

The scientists looked at the health records of more than 95,000 patients, including 22,480 people who used GLP-1s

The most frequent adverse effects are gastrointestinal and dose-related: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort - Typically worst during dose escalation and often resolve or attenuate with continued treatment and slower titration

Nakao A

Clinical data shows that most people regain approximately two-thirds of lost weight within 12 months of stopping GLP-1 therapy

Lastly, ongoing research into the molecular pathways involved in DN will be crucial for identifying new therapeutic targets